Robert Iannone - 26 Feb 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: EVP, Global Head of R&D & CMO
Signature: By: /s/Paz Dizon, as attorney in fact For: Robert Iannone
Issuer symbol: JAZZ
Transactions as of: 26 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 02 Mar 2026, 17:16:13 UTC
Previous filing: 21 Jan 2026
Next filing: 09 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Iannone Robert	EVP, Global Head of R&D & CMO	5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND	By: /s/Paz Dizon, as attorney in fact For: Robert Iannone	02 Mar 2026	0001737329

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Award	$0	+14,822	+18%	$0.000000	95,080	26 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Content

These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.